未处理动脉瘤性蛛网膜下腔出血中血压参数对再出血和结局影响的比较
该回顾性研究基于2016—2023年单中心连续收治的324例动脉瘤性蛛网膜下腔出血患者,比较收缩压与平均动脉压对再出血和3个月不良结局的影响。结果显示仅平均动脉压与再出血(每升高1 mmHg,OR 1.02,95%CI 1.001-1.03,P=0.043)和不良结局(每升高1 mmHg,OR 1.01,95%CI 1.002-1.025,P=0.025)独立相关,收缩压未达统计学显著。作者认为平均动脉压与再出血和不良结局的相关性可能略优于收缩压,需更大规模前瞻性研究识别和减轻这些风险因素。
要点
- 平均动脉压每升高1 mmHg,再出血风险OR 1.02(95%CI 1.001-1.03,P=0.043)。
- 平均动脉压每升高1 mmHg,3个月不良结局OR 1.01(95%CI 1.002-1.025,P=0.025)。
- 收缩压与再出血(P=0.06)及不良结局(P=0.23)均未达统计学显著。
核心结论
- 在未处理动脉瘤性蛛网膜下腔出血中,平均动脉压与再出血和不良结局的相关性可能略优于收缩压。
- 作者认为需要更大规模的前瞻性研究来识别和减轻再出血和不良结局的风险因素。
研究设计与样本
- 回顾性研究,基于前瞻性收集的2016—2023年单中心连续收治的动脉瘤性蛛网膜下腔出血患者队列,共324例(平均年龄57岁,标准差13.4,女性61%)。
- 采用二元回归分析评估血压参数与再出血及不良结局(出院后3个月改良Rankin量表4-6分)的关联。
主要发现
- 症状性再出血发生于34例患者(11%)。
- 再出血患者和不良结局患者记录了更高的血压测量值。
- 平均动脉压每升高1 mmHg与再出血独立相关(OR 1.02,95%CI 1.001-1.03,P=0.043)。
- 平均动脉压每升高1 mmHg与不良结局独立相关(OR 1.01,95%CI 1.002-1.025,P=0.025)。
- 收缩压每升高1 mmHg与再出血(OR 1,95%CI 0.99-1.01,P=0.06)及不良结局(OR 1,95%CI 0.99-1.02,P=0.23)均未达统计学显著。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
- 作者在结论中提出需要更大规模的前瞻性研究来识别和减轻再出血和不良结局的风险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Elevated systolic blood pressure (SBP) has been linked to preprocedural rebleeding risk and poor outcome in patients with aneurysmal subarachnoid hemorrhage (aSAH). This study seeks to compare the effects of SBP and mean arterial pressure (MAP) on rebleeding and functional outcomes in aSAH patients. METHODS: We performed a retrospective study of a prospectively collected cohort of consecutive patients with aSAH admitted to an academic center in 2016-2023. Binary regression analysis was used to determine the association between BP parameters and outcomes including rebleeding and poor outcome defined as modified Rankin Scale 4-6 at 3 months postdischarge. RESULTS: The cohort included 324 patients (mean age 57 years [standard deviation 13.4], 61% female). Symptomatic rebleeding occurred in 34 patients (11%). Higher BP measurements were recorded in patients with rebleeding and poor outcome, however, only MAP met statistical significance for rebleeding (odds ratio {OR} 1.02 for 1 mmHg increase in MAP, 95% confidence interval {CI}: 1.001-1.03, P = 0.043; OR 1 per 1 mmHg increase in SBP, 95% CI 0.99-1.01; P = 0.06)) and for poor outcome (OR 1.01 for 1 mmHg increase in MAP, 95% CI: 1.002-1.025, P = 0.025; OR 1 for 1 mmHg increase in SBP, 95% CI: 0.99-1.02, P = 0.23) independent of other predictors. CONCLUSIONS: MAP may appear to be slightly better correlated with rebleeding and poor outcomes in unsecured aSAH compared to SBP. Larger prospective studies are needed to identify and mitigate risk factors for rebleeding and poor outcome in aSAH patients.
引用
- Haripottawekul A, Persad-Paisley EM, Paracha S, et al. Comparison of the Effects of Blood Pressure Parameters on Rebleeding and Outcomes in Unsecured Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2024. PMID: 38382760. doi:10.1016/j.wneu.2024.02.078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。